Phase 1 clinical trial to assess safety and efficacy of NY-ESO-1-specific TCR T cells in HLA-A∗02:01 patients with advanced soft tissue sarcoma

Pan, Qiuzhong; Weng, Desheng; Liu, Jiayong; Han, Zhaosheng; Ou, Yusheng; Xu, Bushu; Peng, Ruiqing; Que, Yi; Wen, Xizhi; Yang, Jing; Zhong, Shi; Zeng, Lun; Chen, Aiyuan; Gong, Haiping; Lin, Yanmei; Chen, Jiewen; Ma, Ke; Lau, Johnson Y. N.; Li, Yi; Fan, Zhengfu; Zhang, Xing

Published in

Cell Press, Cell Reports Medicine, 8(4), p. 101133, 2023

DOI: 10.1016/j.xcrm.2023.101133

Tools

Export citation

Search in Google Scholar

Phase 1 clinical trial to assess safety and efficacy of NY-ESO-1-specific TCR T cells in HLA-A∗02:01 patients with advanced soft tissue sarcoma

Journal article published in 2023 by Qiuzhong Pan, Desheng Weng, Jiayong Liu, Zhaosheng Han, Yusheng Ou, Bushu Xu, Ruiqing Peng, Yi Que, Xizhi Wen, Jing Yang, Shi Zhong, Lun Zeng, Aiyuan Chen, Haiping Gong, Yanmei Lin and other authors.

This paper is made freely available by the publisher.

Full text: Download

Preprint: archiving allowed

Upload

Postprint: archiving allowed

Upload

Published version: archiving allowed

Upload

Policy details

Data provided by

Published in

Links

Tools

Phase 1 clinical trial to assess safety and efficacy of NY-ESO-1-specific TCR T cells in HLA-A∗02:01 patients with advanced soft tissue sarcoma